AAP
FOLD

Arax Advisory Partners’s Amicus Therapeutics FOLD Stock Holding History

Arax Advisory Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.92K Buy
686
+66
+11% +$946 ﹤0.01% 2442
2025
Q4 		$8.83K Sell
620
-1,079
-64% -$10.6K ﹤0.01% 2538
2025
Q3 		$13.4K Buy
1,699
+1,541
+975% +$11K ﹤0.01% 2473
2025
Q2 		$906 Buy
158
+87
+123% +$561 ﹤0.01% 2805
2025
Q1 		$580 Buy
71
+45
+173% +$416 ﹤0.01% 2516
2024
Q4 		$245 Sell
26
-68
-72% -$707 ﹤0.01% 2379
2024
Q3 		$1K Buy
+94
New +$1.02K ﹤0.01% 2255

Other funds holding FOLD

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return